128 related articles for article (PubMed ID: 38241645)
1. Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights From a Survey Study.
Di Chiara C; Boracchini R; Cantarutti A; Kakkar F; Oletto A; Padoan A; Donà D; Giaquinto C
Pediatr Infect Dis J; 2024 Apr; 43(4):e128-e130. PubMed ID: 38241645
[TBL] [Abstract][Full Text] [Related]
2. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
3. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
Ann Intern Med; 2022 May; 175(5):674-681. PubMed ID: 35157493
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
Monteón V; León-Pérez F; Ancona-León JG; Gutiérrez-Torres G
Salud Publica Mex; 2023 Dec; 66(1, ene-feb):14-16. PubMed ID: 38065105
[TBL] [Abstract][Full Text] [Related]
5. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
[TBL] [Abstract][Full Text] [Related]
6. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
7. Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait.
Alhaddad F; Abdulkareem A; Alsharrah D; Alkandari A; Bin-Hasan S; Al-Ahmad M; Al Hashemi H; Alghounaim M
BMJ Open; 2022 Jun; 12(6):e056371. PubMed ID: 35768102
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
9. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
[TBL] [Abstract][Full Text] [Related]
10. Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study.
Lin DY; Xu Y; Gu Y; Zeng D; Wheeler B; Young H; Moore Z; Sunny SK
Lancet Infect Dis; 2023 Nov; 23(11):1257-1265. PubMed ID: 37336222
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
[TBL] [Abstract][Full Text] [Related]
12. Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19.
Peghin M; De Martino M; Palese A; Chiappinotto S; Fonda F; Gerussi V; Sartor A; Curcio F; Grossi PA; Isola M; Tascini C
Clin Microbiol Infect; 2024 Apr; 30(4):522-530. PubMed ID: 38141821
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
14. BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study.
Yung CF; Pang D; Kam KQ; Lye DC; Ong B; Chong CY; Tan KB
Lancet Child Adolesc Health; 2023 Jul; 7(7):463-470. PubMed ID: 37201540
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological assessment of SARS-CoV-2 reinfection.
Almadhi M; Alsayyad AS; Conroy R; Atkin S; Awadhi AA; Al-Tawfiq JA; AlQahtani M
Int J Infect Dis; 2022 Oct; 123():9-16. PubMed ID: 35931371
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents.
Patalon T; Saciuk Y; Perez G; Peretz A; Ben-Tov A; Gazit S
J Pediatr; 2023 Jun; 257():113371. PubMed ID: 36870558
[TBL] [Abstract][Full Text] [Related]
17. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children.
Ikuse T; Aizawa Y; Hasegawa S; Takahashi M; Hayashi T; Kon M; Tamura T; Matsumoto H; Saitoh A
J Pediatric Infect Dis Soc; 2023 Dec; 12(12):634-637. PubMed ID: 37936292
[TBL] [Abstract][Full Text] [Related]
19. First documented reinfection of SARS-COV-2 in second wave from Pakistan.
Ul-Haq Z; Khan A; Fazid S; Noor F; Yousafzai YM; Sherin A
J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S704-S705. PubMed ID: 33754536
[TBL] [Abstract][Full Text] [Related]
20. Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
Kubale J; Balmaseda A; Frutos AM; Sanchez N; Plazaola M; Ojeda S; Saborio S; Lopez R; Barilla C; Vasquez G; Moreira H; Gajewski A; Campredon L; Maier HE; Chowdhury M; Cerpas C; Harris E; Kuan G; Gordon A
JAMA Netw Open; 2022 Jun; 5(6):e2218794. PubMed ID: 35759261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
